Marked Improvement after Globus Pallidus Deep Brain Stimulation in Dystonia-24 with a Novel ANO3 Variant: A Case Report and Literature Review

Running title: GPi-DBS for DYT24 and Novel ANO3 Mutation Dystonia-24 (DYT-24, previously known as DYT-ANO3) is a rare autosomal dominant movement disorder caused by mutation in the anoctamin 3 (ANO3) gene, often presenting with craniocervical involvement. 1 Pharmacological interventions and botulinum toxin injections are conventional management strategies; however, DYT-24 frequently shows marked resistance to these conservative therapies, necessitating more invasive neuromodulation. [1][2]2][3][4][5][6][7] Although a few studies have suggested the efficacy of deep brain stimulation (DBS), detailed clinical outcomes remain limited. [1][2]2][3][4][5][6][7] Here, we report a Japanese man with DYT-24 in whom genetic testing identified a novel ANO3 variant (c.1705G>T, p.V569L), and who showed marked clinical improvement after GPi-DBS.A 53-year-old man was admitted to our department with progressively worsening dystonic symptoms.At the age of 18 years, the patient first presented with craniocervical dystonia, without significant interference in daily activities.At 45 years of age, the patient developed oral dystonia, resulting in dysarthria.At the age of 51 years, the patient was referred to another neurology clinic because of truncal flexion, which prompted him to LETTER TO THE EDITOR transition from working in the foundry industry to employment as a forklift driver.Pharmacological therapy, including trihexylphenidyl, clonazepam, tizanidine hydrochloride, and diazepam, was initiated along with botulinum injections; however, these treatments were ineffective.Family history suggested that his father, who had passed away, exhibited similar symptoms of craniocervical dystonia and dysarthria but did not seek medical attention.The patient had no contact with his paternal relatives, and detailed information regarding the paternal family history was unavailable.No history of consanguinity existed.On admission, neurological examination revealed generalized dystonia, including craniocervical dystonia, blepharospasm, oral dystonia, dystonia of both upper limbs and the trunk, and tremor in both upper limbs.Dystonia of the neck and bilateral upper limbs worsened during walking (Video 1).Blood and cerebrospinal fluid analyses were normal.Magnetic resonance imaging and single-photon emission computed tomography findings were unremarkable.Considering the positive family history, early onset, and generalized dystonia with predominant craniocervical involvement, an inherited form of dystonia was suspected.Genetic analysis identified a novel ANO3 variant (c.1705G>T, p.V569L), classified as a variant of uncertain significance according to ACMG/AMP criteria.At 53 years of age,

Authors

Institutions

Publication Details

Journal
Journal of Movement Disorders
Published
2026-07-24
DOI
https://doi.org/10.14802/jmd.26139
Primary Topic
Neurological disorders and treatments
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Marked Improvement after Globus Pallidus Deep Brain Stimulation in Dystonia-24 with a Novel ANO3 Variant: A Case Report and Literature Review

Tomoyo Hashimoto, Yasushi Miyagi, K Tachibana, Kazumasa Okada et al.
Journal of Movement Disorders
Neurological disorders and treatments
article

Marked Improvement after Globus Pallidus Deep Brain Stimulation in Dystonia-24 with a Novel ANO3 Variant: A Case Report and Literature Review

Tomoyo Hashimoto, Yasushi Miyagi, K Tachibana, Kazumasa Okada, Masataka Yamashiro, Ryosuke Miyamoto, Yuishin Izumi
article en

Abstract

Running title: GPi-DBS for DYT24 and Novel ANO3 Mutation Dystonia-24 (DYT-24, previously known as DYT-ANO3) is a rare autosomal dominant movement disorder caused by mutation in the anoctamin 3 (ANO3) gene, often presenting with craniocervical involvement. 1 Pharmacological interventions and botulinum toxin injections are conventional management strategies; however, DYT-24 frequently shows marked resistance to these conservative therapies, necessitating more invasive neuromodulation. [1][2]2][3][4][5][6][7] Although a few studies have suggested the efficacy of deep brain stimulation (DBS), detailed clinical outcomes remain limited. [1][2]2][3][4][5][6][7] Here, we report a Japanese man with DYT-24 in whom genetic testing identified a novel ANO3 variant (c.1705G>T, p.V569L), and who showed marked clinical improvement after GPi-DBS.A 53-year-old man was admitted to our department with progressively worsening dystonic symptoms.At the age of 18 years, the patient first presented with craniocervical dystonia, without significant interference in daily activities.At 45 years of age, the patient developed oral dystonia, resulting in dysarthria.At the age of 51 years, the patient was referred to another neurology clinic because of truncal flexion, which prompted him to LETTER TO THE EDITOR transition from working in the foundry industry to employment as a forklift driver.Pharmacological therapy, including trihexylphenidyl, clonazepam, tizanidine hydrochloride, and diazepam, was initiated along with botulinum injections; however, these treatments were ineffective.Family history suggested that his father, who had passed away, exhibited similar symptoms of craniocervical dystonia and dysarthria but did not seek medical attention.The patient had no contact with his paternal relatives, and detailed information regarding the paternal family history was unavailable.No history of consanguinity existed.On admission, neurological examination revealed generalized dystonia, including craniocervical dystonia, blepharospasm, oral dystonia, dystonia of both upper limbs and the trunk, and tremor in both upper limbs.Dystonia of the neck and bilateral upper limbs worsened during walking (Video 1).Blood and cerebrospinal fluid analyses were normal.Magnetic resonance imaging and single-photon emission computed tomography findings were unremarkable.Considering the positive family history, early onset, and generalized dystonia with predominant craniocervical involvement, an inherited form of dystonia was suspected.Genetic analysis identified a novel ANO3 variant (c.1705G>T, p.V569L), classified as a variant of uncertain significance according to ACMG/AMP criteria.At 53 years of age,

Journal of Movement Disorders
University of Occupational and Environmental Health Japan (JP), Mirai Hospital (JP), Tokushima University (JP)
Industry, innovation and infrastructure
Openalex Percentile: Top 8%
Neurological disorders and treatments
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.